Offshore
Video
Startup Archive
RT @ArthurMacwaters: Parker gave a great talk about this at a YC reunion recently
He pointed out that building a hyperspecialized company that carefully avoids markets held by large incumbents is actually dumb
You have to kill some giants to become the king.
So take on the incumbents and do the stack better
tweet
RT @ArthurMacwaters: Parker gave a great talk about this at a YC reunion recently
He pointed out that building a hyperspecialized company that carefully avoids markets held by large incumbents is actually dumb
You have to kill some giants to become the king.
So take on the incumbents and do the stack better
Rippling founder Parker Conrad on the opportunity in building “compound startups”
Y Combinator CEO Garry Tan points out that the classic startup advice is “do one thing and do it extremely well,” but Parker took a different approach building Rippling that he calls the “compound startup.” He set out to solve multiple problems for their customers simultaneously.
Parker elaborates on this:
“I think it actually resembles a lot of software companies that were built 20+ years ago. If you look at companies like SAP, Oracle, and Microsoft, they actually look like compound software businesses… What happened is I think there was this moment in time where it really was possible to do one narrow thing because there was so much greenfield territory in software as everything shifted from on-prem to the cloud. You could go out and do this really narrow thing and turn it into a SaaS company. Almost all of these things ended up — at least for a period of time — being worth low-single-digit billions of dollars. And it was really easy to find a niche.”
But Parker believes this approach is suboptimal because it limits the types of problems you can solve for your customers — especially big customers.
“You can actually just wipe out a lot of work and make things function much better if you can take on a whole host of interrelated applications and build one comprehensive solution.”
Parker argues that if you can solve multiple problems for your customers with parallel applications, your product/market fit becomes much more powerful and harder to displace.
The other argument in favor of the compound startup approach is that sales and marketing has gotten much harder and less efficient for software businesses:
“You see this at every stage, but over the last five years, public companies are spending 50% more on sales and marketing, but they’re adding 10% less in new ARR with that increase in spend. Fundamentally, the business model for a lot of software is just broken. There’s too many businesses.”
Parker also believes AI sales agents will completely destroy outbound as a channel if they do eventually end up working.
Video source: @ycombinator (2025) tweet
Offshore
Photo
Dimitry Nakhla | Babylon Capital®
ASML Holding $ASML Q4 Earnings Report🎯
Rev: €9.26B vs €9.02B est ✅ | +28% YoY
EPS: €6.85 vs €6.73 est ✅ | +31% YoY
___
Net bookings: €7.09B vs €3.53B est ✅
___
Guidance 📈
Rev Q1 2025: €7.5B-€8.0B vs €7.25B est ✅
Rev FY 2025: €30B-€35B vs $32.02B est ✅ https://t.co/BpEGp9OFEX
tweet
ASML Holding $ASML Q4 Earnings Report🎯
Rev: €9.26B vs €9.02B est ✅ | +28% YoY
EPS: €6.85 vs €6.73 est ✅ | +31% YoY
___
Net bookings: €7.09B vs €3.53B est ✅
___
Guidance 📈
Rev Q1 2025: €7.5B-€8.0B vs €7.25B est ✅
Rev FY 2025: €30B-€35B vs $32.02B est ✅ https://t.co/BpEGp9OFEX
tweet
Offshore
Photo
InsideArbitrage
UK's Competition and Markets Authority (CMA) announced the launch of the merger inquiry for the acquisition of ChampionX $CHX by Schlumberger $SLB.
🧪The initial period will commence on January 30, 2025.
🧪The deadline for @CMAgovUK to announce its decision on whether to refer the merger for a phase 2 investigation is March 27, 2025.
tweet
UK's Competition and Markets Authority (CMA) announced the launch of the merger inquiry for the acquisition of ChampionX $CHX by Schlumberger $SLB.
🧪The initial period will commence on January 30, 2025.
🧪The deadline for @CMAgovUK to announce its decision on whether to refer the merger for a phase 2 investigation is March 27, 2025.
tweet
InsideArbitrage
$CPF Board authorizes new $30 million share repurchase program (4% of its current market cap) which replaces the prior $20 million share repurchase plan of January 2024
Q4 & FY 2024 Highlights
💰 Net Income: $11.3M ($0.42/share) Q4 | $53.4M ($1.97/share) FY
📈Net interest margin rose to 3.17%, up 10 bps from 3.07% last quarter
💵 Dividends & Buybacks: Quarterly dividend up 3.8% to $0.27/share | New $30M repurchase plan for 2025
🏦 Milestone: Central Pacific Bank joins the Federal Reserve System
▪️ In 2024, the company repurchased 49,960 shares for $0.9M (avg. $18.92/share) and returned $29.1M to shareholders via dividends and buybacks. 💰📈
tweet
$CPF Board authorizes new $30 million share repurchase program (4% of its current market cap) which replaces the prior $20 million share repurchase plan of January 2024
Q4 & FY 2024 Highlights
💰 Net Income: $11.3M ($0.42/share) Q4 | $53.4M ($1.97/share) FY
📈Net interest margin rose to 3.17%, up 10 bps from 3.07% last quarter
💵 Dividends & Buybacks: Quarterly dividend up 3.8% to $0.27/share | New $30M repurchase plan for 2025
🏦 Milestone: Central Pacific Bank joins the Federal Reserve System
▪️ In 2024, the company repurchased 49,960 shares for $0.9M (avg. $18.92/share) and returned $29.1M to shareholders via dividends and buybacks. 💰📈
tweet
Quiver Quantitative
The national debt increased by about $647M in the first week of Trump’s presidency.
Obviously too early for this to mean anything yet, it’s noisy data, but here’s how that compares to past years over a similar time period:
2024: +$58B
2023: +$3B
2022: +$51B
2021: +$3B
2020: +$33B
2019: +$2B
2018: +$236M
2017: -$10B
2016: +$30B
Planning on posting updates as more policies get enacted, and we get a larger sample size.
tweet
The national debt increased by about $647M in the first week of Trump’s presidency.
Obviously too early for this to mean anything yet, it’s noisy data, but here’s how that compares to past years over a similar time period:
2024: +$58B
2023: +$3B
2022: +$51B
2021: +$3B
2020: +$33B
2019: +$2B
2018: +$236M
2017: -$10B
2016: +$30B
Planning on posting updates as more policies get enacted, and we get a larger sample size.
tweet
Offshore
Photo
Dimitry Nakhla | Babylon Capital®
6 months ago I suggested $DHR was trading for a substantial premium at $240💵 & that I’d be more interested closer to $200💵
After its Q4 earnings report, $DHR shares are down ~6% & down over the past 6 months
___
As I stated in the analysis (post shared below):
“As you can see, $DHR needs to trade above 32x to have attractive return potential
While possible, I wouldn’t want to rely on that assumption as it doesn’t leave us with any margin of safety
While the 10-year mean multiple is 25.18x, I’d be content relying on somewhere closer to 27x - 28x earnings given $DHR quality, culture, competitive advantage, earnings growth rate & the quality of earnings, & long-term tailwinds in the sector
Yet, even at 27x - 28x earnings, the return potential outlook is bleak
Today at $240💵 $DHR is trading at a substantial premium
I’d become interested in $DHR closer to $200💵 or at ~25.50x NTM earnings (roughly 16.7% below today’s price)”
A sober valuation analysis on $DHR 🧘🏽♂️
•NTM P/E Ratio: 30.69x
•10-Year Mean: 25.18x
•NTM FCF Yield: 4.34%
•10-Year Mean: 3.24%
As you can see, $DHR appears to be trading above fair value
Going forward, investors can receive ~18% LESS in earnings per share & ~25% LESS in FCF per share 🧠***
Before we get into valuation, let’s take a look at why $DHR is a quality business
BALANCE SHEET✅
•Cash & Short-Term Inv: $7.03B
•Long-Term Debt: $16.42B
$DHR has a great balance sheet, an A- S&P Credit Rating, & 22x FFO Interest Coverage
RETURN ON CAPITAL🆗*
•2019: 6.2%
•2020: 7.8%
•2021: 10.3%
•2022: 10.7%
•2023: 7.4%
•LTM: 7.2%
*ROIC relatively low partly due to $DHR growth strategy (acquisitions, capital allocation, etc)
RETURN ON EQUITY🆗
•2019: 8.3%
•2020: 10.8%
•2021: 12.8%
•2022: 13.3%
•2023: 8.2%
•LTM: 7.8%
$DHR has decent return metrics, highlighting the financial efficiency of the business
REVENUES✅
•2018: $17.05B
•2023: $23.89B
•CAGR: 6.97%
FREE CASH FLOW✅
•2018: $3.44B
•2023: $5.78B
•CAGR: 10.93%
NORMALIZED EPS✅
•2018: $7.58
•2023: $4.52
•CAGR: 10.89%
SHARE BUYBACKS❌
•2018 Shares Outstanding: 0.70B
•LTM Shares Outstanding: 0.74B
MARGINS✅
•LTM Gross Margins: 58.9%
•LTM Operating Margins: 21.9%
•LTM Net Income Margins: 17.1%
***NOW TO VALUATION 🧠
As stated above, investors can expect to receive ~18% LESS in EPS & ~25% LESS in FCF per share
Using Benjamin Graham’s 2G rule of thumb, $DHR has to grow earnings at a 15.35% CAGR over the next several years to justify its valuation
Today, analysts anticipate 2024 - 2026 EPS growth over the next few years to be less than the (15.35%) required growth rate:
2024E: $7.62 (0.5% YoY) *FY Dec
2025E: $8.74 (14.8% YoY)
2026E: $9.71 (11.0% YoY)
$DHR has a decent track record of meeting analyst estimates ~2 years out, so let’s assume $DHR ends 2026 with $9.71 in EPS & see its CAGR potential assuming different multiples
32x P/E: $310.72💵 … ~11.3% CAGR
28x P/E: $271.88💵 … ~5.5% CAGR
27x P/E: $262.16💵 … ~4.0% CAGR
26x P/E: $252.46💵 … ~2.5% CAGR
25x P/E: $242.75💵 … ~1.0% CAGR
As you can see, $DHR needs to trade above 32x to have attractive return potential
While possible, I wouldn’t want to rely on that assumption as it doesn’t leave us with any margin of safety
While the 10-year mean multiple is 25.18x, I’d be content relying on somewhere closer to 27x - 28x earnings given $DHR quality, culture, competitive advantage, earnings growth rate & the quality of earnings, & long-term tailwinds in the sector
Yet, even at 27x - 28x earnings, the return potential outlook is bleak
Today at $240💵 $DHR is trading at a substantial premium
I’d become interested in $DHR closer to $200💵 or at ~25.50x NTM earnings (roughly 16.7% below tod[...]
6 months ago I suggested $DHR was trading for a substantial premium at $240💵 & that I’d be more interested closer to $200💵
After its Q4 earnings report, $DHR shares are down ~6% & down over the past 6 months
___
As I stated in the analysis (post shared below):
“As you can see, $DHR needs to trade above 32x to have attractive return potential
While possible, I wouldn’t want to rely on that assumption as it doesn’t leave us with any margin of safety
While the 10-year mean multiple is 25.18x, I’d be content relying on somewhere closer to 27x - 28x earnings given $DHR quality, culture, competitive advantage, earnings growth rate & the quality of earnings, & long-term tailwinds in the sector
Yet, even at 27x - 28x earnings, the return potential outlook is bleak
Today at $240💵 $DHR is trading at a substantial premium
I’d become interested in $DHR closer to $200💵 or at ~25.50x NTM earnings (roughly 16.7% below today’s price)”
A sober valuation analysis on $DHR 🧘🏽♂️
•NTM P/E Ratio: 30.69x
•10-Year Mean: 25.18x
•NTM FCF Yield: 4.34%
•10-Year Mean: 3.24%
As you can see, $DHR appears to be trading above fair value
Going forward, investors can receive ~18% LESS in earnings per share & ~25% LESS in FCF per share 🧠***
Before we get into valuation, let’s take a look at why $DHR is a quality business
BALANCE SHEET✅
•Cash & Short-Term Inv: $7.03B
•Long-Term Debt: $16.42B
$DHR has a great balance sheet, an A- S&P Credit Rating, & 22x FFO Interest Coverage
RETURN ON CAPITAL🆗*
•2019: 6.2%
•2020: 7.8%
•2021: 10.3%
•2022: 10.7%
•2023: 7.4%
•LTM: 7.2%
*ROIC relatively low partly due to $DHR growth strategy (acquisitions, capital allocation, etc)
RETURN ON EQUITY🆗
•2019: 8.3%
•2020: 10.8%
•2021: 12.8%
•2022: 13.3%
•2023: 8.2%
•LTM: 7.8%
$DHR has decent return metrics, highlighting the financial efficiency of the business
REVENUES✅
•2018: $17.05B
•2023: $23.89B
•CAGR: 6.97%
FREE CASH FLOW✅
•2018: $3.44B
•2023: $5.78B
•CAGR: 10.93%
NORMALIZED EPS✅
•2018: $7.58
•2023: $4.52
•CAGR: 10.89%
SHARE BUYBACKS❌
•2018 Shares Outstanding: 0.70B
•LTM Shares Outstanding: 0.74B
MARGINS✅
•LTM Gross Margins: 58.9%
•LTM Operating Margins: 21.9%
•LTM Net Income Margins: 17.1%
***NOW TO VALUATION 🧠
As stated above, investors can expect to receive ~18% LESS in EPS & ~25% LESS in FCF per share
Using Benjamin Graham’s 2G rule of thumb, $DHR has to grow earnings at a 15.35% CAGR over the next several years to justify its valuation
Today, analysts anticipate 2024 - 2026 EPS growth over the next few years to be less than the (15.35%) required growth rate:
2024E: $7.62 (0.5% YoY) *FY Dec
2025E: $8.74 (14.8% YoY)
2026E: $9.71 (11.0% YoY)
$DHR has a decent track record of meeting analyst estimates ~2 years out, so let’s assume $DHR ends 2026 with $9.71 in EPS & see its CAGR potential assuming different multiples
32x P/E: $310.72💵 … ~11.3% CAGR
28x P/E: $271.88💵 … ~5.5% CAGR
27x P/E: $262.16💵 … ~4.0% CAGR
26x P/E: $252.46💵 … ~2.5% CAGR
25x P/E: $242.75💵 … ~1.0% CAGR
As you can see, $DHR needs to trade above 32x to have attractive return potential
While possible, I wouldn’t want to rely on that assumption as it doesn’t leave us with any margin of safety
While the 10-year mean multiple is 25.18x, I’d be content relying on somewhere closer to 27x - 28x earnings given $DHR quality, culture, competitive advantage, earnings growth rate & the quality of earnings, & long-term tailwinds in the sector
Yet, even at 27x - 28x earnings, the return potential outlook is bleak
Today at $240💵 $DHR is trading at a substantial premium
I’d become interested in $DHR closer to $200💵 or at ~25.50x NTM earnings (roughly 16.7% below tod[...]
Offshore
Dimitry Nakhla | Babylon Capital® 6 months ago I suggested $DHR was trading for a substantial premium at $240💵 & that I’d be more interested closer to $200💵 After its Q4 earnings report, $DHR shares are down ~6% & down over the past 6 months ___ As I stated…
ay’s price)
At that price, I can reasonably expect ~12% CAGR while assuming 27x & ~10.2% CAGR while assuming 26x, a multiple I view as fair for $DHR
#stocks #investing
___
𝐃𝐈𝐒𝐂𝐋𝐎𝐒𝐔𝐑𝐄‼️: 𝐓𝐡𝐢𝐬 𝐢𝐬 𝐍𝐎𝐓 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐀𝐝𝐯𝐢𝐜𝐞. 𝐁𝐚𝐛𝐲𝐥𝐨𝐧 𝐂𝐚𝐩𝐢𝐭𝐚𝐥® 𝐚𝐧𝐝 𝐢𝐭𝐬 𝐫𝐞𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐯𝐞𝐬 𝐦𝐚𝐲 𝐡𝐚𝐯𝐞 𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐬𝐞𝐜𝐮𝐫𝐢𝐭𝐢𝐞𝐬 𝐝𝐢𝐬𝐜𝐮𝐬𝐬𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐭𝐰𝐞𝐞𝐭.
𝐓𝐡𝐞 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐜𝐨𝐧𝐭𝐚𝐢𝐧𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐭𝐰𝐞𝐞𝐭 𝐢𝐬 𝐢𝐧𝐭𝐞𝐧𝐝𝐞𝐝 𝐟𝐨𝐫 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐩𝐮𝐫𝐩𝐨𝐬𝐞𝐬 𝐨𝐧𝐥𝐲 𝐚𝐧𝐝 𝐬𝐡𝐨𝐮𝐥𝐝 𝐧𝐨𝐭 𝐛𝐞 𝐜𝐨𝐧𝐬𝐭𝐫𝐮𝐞𝐝 𝐚𝐬 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐚𝐝𝐯𝐢𝐜𝐞 𝐭𝐨 𝐦𝐞𝐞𝐭 𝐭𝐡𝐞 𝐬𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐧𝐞𝐞𝐝𝐬 𝐨𝐟 𝐚𝐧𝐲 𝐢𝐧𝐝𝐢𝐯𝐢𝐝𝐮𝐚𝐥 𝐨𝐫 𝐬𝐢𝐭𝐮𝐚𝐭𝐢𝐨𝐧. 𝐏𝐚𝐬𝐭 𝐩𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞 𝐢𝐬 𝐧𝐨 𝐠𝐮𝐚𝐫𝐚𝐧𝐭𝐞𝐞 𝐨𝐟 𝐟𝐮𝐭𝐮𝐫𝐞 𝐫𝐞𝐬𝐮𝐥𝐭𝐬.
𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐜𝐨𝐧𝐭𝐚𝐢𝐧𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐭𝐰𝐞𝐞𝐭 𝐡𝐚𝐬 𝐛𝐞𝐞𝐧 𝐨𝐛𝐭𝐚𝐢𝐧𝐞𝐝 𝐟𝐫𝐨𝐦 𝐬𝐨𝐮𝐫𝐜𝐞𝐬 𝐛𝐞𝐥𝐢𝐞𝐯𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐫𝐞𝐥𝐢𝐚𝐛𝐥𝐞, 𝐛𝐮𝐭 𝐢𝐬 𝐧𝐨𝐭 𝐠𝐮𝐚𝐫𝐚𝐧𝐭𝐞𝐞𝐝. - Dimitry Nakhla | Babylon Capital® tweet
At that price, I can reasonably expect ~12% CAGR while assuming 27x & ~10.2% CAGR while assuming 26x, a multiple I view as fair for $DHR
#stocks #investing
___
𝐃𝐈𝐒𝐂𝐋𝐎𝐒𝐔𝐑𝐄‼️: 𝐓𝐡𝐢𝐬 𝐢𝐬 𝐍𝐎𝐓 𝐈𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐀𝐝𝐯𝐢𝐜𝐞. 𝐁𝐚𝐛𝐲𝐥𝐨𝐧 𝐂𝐚𝐩𝐢𝐭𝐚𝐥® 𝐚𝐧𝐝 𝐢𝐭𝐬 𝐫𝐞𝐩𝐫𝐞𝐬𝐞𝐧𝐭𝐚𝐭𝐢𝐯𝐞𝐬 𝐦𝐚𝐲 𝐡𝐚𝐯𝐞 𝐩𝐨𝐬𝐢𝐭𝐢𝐨𝐧𝐬 𝐢𝐧 𝐭𝐡𝐞 𝐬𝐞𝐜𝐮𝐫𝐢𝐭𝐢𝐞𝐬 𝐝𝐢𝐬𝐜𝐮𝐬𝐬𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐭𝐰𝐞𝐞𝐭.
𝐓𝐡𝐞 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐜𝐨𝐧𝐭𝐚𝐢𝐧𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐭𝐰𝐞𝐞𝐭 𝐢𝐬 𝐢𝐧𝐭𝐞𝐧𝐝𝐞𝐝 𝐟𝐨𝐫 𝐢𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧𝐚𝐥 𝐩𝐮𝐫𝐩𝐨𝐬𝐞𝐬 𝐨𝐧𝐥𝐲 𝐚𝐧𝐝 𝐬𝐡𝐨𝐮𝐥𝐝 𝐧𝐨𝐭 𝐛𝐞 𝐜𝐨𝐧𝐬𝐭𝐫𝐮𝐞𝐝 𝐚𝐬 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐚𝐝𝐯𝐢𝐜𝐞 𝐭𝐨 𝐦𝐞𝐞𝐭 𝐭𝐡𝐞 𝐬𝐩𝐞𝐜𝐢𝐟𝐢𝐜 𝐧𝐞𝐞𝐝𝐬 𝐨𝐟 𝐚𝐧𝐲 𝐢𝐧𝐝𝐢𝐯𝐢𝐝𝐮𝐚𝐥 𝐨𝐫 𝐬𝐢𝐭𝐮𝐚𝐭𝐢𝐨𝐧. 𝐏𝐚𝐬𝐭 𝐩𝐞𝐫𝐟𝐨𝐫𝐦𝐚𝐧𝐜𝐞 𝐢𝐬 𝐧𝐨 𝐠𝐮𝐚𝐫𝐚𝐧𝐭𝐞𝐞 𝐨𝐟 𝐟𝐮𝐭𝐮𝐫𝐞 𝐫𝐞𝐬𝐮𝐥𝐭𝐬.
𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 𝐜𝐨𝐧𝐭𝐚𝐢𝐧𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐭𝐰𝐞𝐞𝐭 𝐡𝐚𝐬 𝐛𝐞𝐞𝐧 𝐨𝐛𝐭𝐚𝐢𝐧𝐞𝐝 𝐟𝐫𝐨𝐦 𝐬𝐨𝐮𝐫𝐜𝐞𝐬 𝐛𝐞𝐥𝐢𝐞𝐯𝐞𝐝 𝐭𝐨 𝐛𝐞 𝐫𝐞𝐥𝐢𝐚𝐛𝐥𝐞, 𝐛𝐮𝐭 𝐢𝐬 𝐧𝐨𝐭 𝐠𝐮𝐚𝐫𝐚𝐧𝐭𝐞𝐞𝐝. - Dimitry Nakhla | Babylon Capital® tweet
Dimitry Nakhla | Babylon Capital®
RT @DimitryNakhla: @investsavuri I prefer $DHR over $TMO (in general), yet given today’s valuations relative to growth I prefer $TMO
tweet
RT @DimitryNakhla: @investsavuri I prefer $DHR over $TMO (in general), yet given today’s valuations relative to growth I prefer $TMO
tweet
Offshore
Photo
Dimitry Nakhla | Babylon Capital®
On 11/15/24 I stated that $TMO is more attractive than $DHR given their respective valuations at that time 💵
Since then?
$TMO +12.30% 📈
$DHR +0.26% 🟰 https://t.co/DfPKQQbuEQ
tweet
On 11/15/24 I stated that $TMO is more attractive than $DHR given their respective valuations at that time 💵
Since then?
$TMO +12.30% 📈
$DHR +0.26% 🟰 https://t.co/DfPKQQbuEQ
@investsavuri I prefer $DHR over $TMO (in general), yet given today’s valuations relative to growth I prefer $TMO tweet